Rheumatic Disorders Drugs Market

Rheumatic Disorders Drugs Market: By Site of Action - (Acting on Tumor Necrosis Factor-Alpha, Acting on Interleukins and Interleukin Receptors, Acting on Protein Kinases, Acting on Cell Surface Antigens, Acting on Hormones and Hormone Receptors and Others

Request Sample Request Discount
  • Status : Ongoing
  • Published on: Feb 2021
  • Report ID: KDMI-5410
  • Available Format: PDF/Excel/DOC


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Rheumatic Disorders Drugs Market

Request Sample

Industry Insights

The rheumatic disorders drugs market is anticipated to flourish at a CAGR of 4.8% over the forecast period i.e. 2020-2025. Further, the market for rheumatic disorders drugs was valued at USD XXX.X Million in 2020.

Growth Drivers – Rheumatic Disorders Drugs Market

Increasing Cases of Rheumatic Disorders

Increasing incidence of indications of many rheumatic disorders and rising old age population of the globe is a major growth driver of global rheumatic disorders drugs market. Further, it is anticipated that number of patients living with OA is anticipated to increase by 10.1% during 2020-2025. This factor is further expected to strengthen the growth of global rheumatic disorders drugs market.

Launch of Innovative and Expansion of Product Line

Entry of new products in the market is set to drive the market growth during the forecast period. Various major market players are focusing on introduction and expansion of their product portfolio. For instance, Ardea Biosciences received approval from FDA for Duzallo in 2019. Further, development of new drugs help to cure the diseases more effectively and are witnessing widescale adoption in various developed nations.

Barriers – Rheumatic Disorders Drugs Market

Erosion of Biosimilars

Due to recent and upcoming expiries, biosimilars are likely to suffer from erosion in the years ahead. This will result in revenue decline and reduced market dominance of major players.

Segmentation Analysis

The rheumatic disorders drugs market by site of action is segment into acting on tumor necrosis factor-alpha, acting on interleukins and interleukin receptors, acting on protein kinases, acting on cell surface antigens, acting on hormones & hormone receptors and others. The market for acting on tumor necrosis factor-alpha acting on tumor is anticipated to witness significant growth during the forecast period. Factors such as growing prevalence of rheumatic disorder is anticipated to drive the growth global rheumatic disorders market.
Further, global rheumatic disorders drugs market is also segmented by application into rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus and psoriatic arthritis. Rheumatoid arthritis segment captured significant market share during the forecast period. Further, osteoarthritis segment is anticipated to witness highest growth in the upcoming years.

Geographical Analysis

Geographically, the report offers analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In rheumatic disorders drugs market, North America captured the largest percentage of market in global rheumatic disorders drugs market. With a market share of approximately 41.3% in 2020, U.S. market contributed majorly in global rheumatic disorders drugs market. It is anticipated that one in four adults are diagnosed with rheumatic disorder in America. Addition to that, favorable government policies is envisioned to bolster the growth of global rheumatic disorders drugs market. Asia Pacific rheumatic disorders drugs market is anticipated to witness robust growth during the forecast period. Base of large patient population and rising government focus to boost healthcare in the region is anticipated to impel the growth of Asia Pacific rheumatic disorders drugs market.

Competitive Landscape

The report profiles various major market players such as;
- AbbVie
- Amgen
- Johnson & Johnson
- Novartis
- Pfizer
- Roche
- Eli Lilly
- Bristol-Myers Squibb
- Other Major & Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).
The study also provides company’s positioning and market share in rheumatic disorders drugs market.

Timeline Considered for Analysis:

- 2014 to 2019: Historical Review
- 2020: Base Year
- 2020 to 2025: Forecast Period

Research Scope and Deliverables

Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the global rheumatic disorders drugs market by the following segments:
- Site of Action
- Application

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Rheumatic Disorders Drugs Industry Report:

- What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

Custom Research Requirement? Questions to ask?

Get in touch

Custom Research requirement.

Go Up